BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aherne CM, Saeedi B, Collins CB, Masterson JC, McNamee EN, Perrenoud L, Rapp CR, Curtis VF, Bayless A, Fletcher A. Epithelial-specific A2B adenosine receptor signaling protects the colonic epithelial barrier during acute colitis. Mucosal Immunol. 2015;8:1324-1338. [PMID: 25850656 DOI: 10.1038/mi.2015.22] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 8.8] [Reference Citation Analysis]
Number Citing Articles
1 Kumar T, Pandey R, Chauhan NS. Hypoxia Inducible Factor-1α: The Curator of Gut Homeostasis. Front Cell Infect Microbiol 2020;10:227. [PMID: 32500042 DOI: 10.3389/fcimb.2020.00227] [Cited by in Crossref: 20] [Cited by in F6Publishing: 5] [Article Influence: 20.0] [Reference Citation Analysis]
2 Alexeev EE, Dowdell AS, Henen MA, Lanis JM, Lee JS, Cartwright IM, Schaefer REM, Ornelas A, Onyiah JC, Vögeli B, Colgan SP. Microbial-derived indoles inhibit neutrophil myeloperoxidase to diminish bystander tissue damage. FASEB J 2021;35:e21552. [PMID: 33826788 DOI: 10.1096/fj.202100027R] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Inami A, Kiyono H, Kurashima Y. ATP as a Pathophysiologic Mediator of Bacteria-Host Crosstalk in the Gastrointestinal Tract. Int J Mol Sci 2018;19:E2371. [PMID: 30103545 DOI: 10.3390/ijms19082371] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
4 Andrés RM, Terencio MC, Arasa J, Payá M, Valcuende-cavero F, Navalón P, Montesinos MC. Adenosine A2A and A2B Receptors Differentially Modulate Keratinocyte Proliferation: Possible Deregulation in Psoriatic Epidermis. Journal of Investigative Dermatology 2017;137:123-31. [DOI: 10.1016/j.jid.2016.07.028] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
5 Yuan X, Berg N, Lee JW, Le TT, Neudecker V, Jing N, Eltzschig H. MicroRNA miR-223 as regulator of innate immunity. J Leukoc Biol 2018;104:515-24. [PMID: 29969525 DOI: 10.1002/JLB.3MR0218-079R] [Cited by in Crossref: 75] [Cited by in F6Publishing: 43] [Article Influence: 25.0] [Reference Citation Analysis]
6 Bowser JL, Lee JW, Yuan X, Eltzschig HK. The hypoxia-adenosine link during inflammation. J Appl Physiol (1985). 2017;123:1303-1320. [PMID: 28798196 DOI: 10.1152/japplphysiol.00101.2017] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 11.8] [Reference Citation Analysis]
7 Müller CE, Baqi Y, Hinz S, Namasivayam V. Medicinal Chemistry of A2B Adenosine Receptors. In: Borea PA, Varani K, Gessi S, Merighi S, Vincenzi F, editors. The Adenosine Receptors. Cham: Springer International Publishing; 2018. pp. 137-68. [DOI: 10.1007/978-3-319-90808-3_6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
8 Lee JS, Wang RX, Goldberg MS, Clifford GP, Kao DJ, Colgan SP. Microbiota-Sourced Purines Support Wound Healing and Mucous Barrier Function. iScience 2020;23:101226. [PMID: 32554188 DOI: 10.1016/j.isci.2020.101226] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
9 Zhao HW, Yue YH, Han H, Chen XL, Lu YG, Zheng JM, Hou HT, Lang XM, He LL, Hu QL, Dun ZQ. Effect of toll-like receptor 3 agonist poly I:C on intestinal mucosa and epithelial barrier function in mouse models of acute colitis. World J Gastroenterol 2017;23:999-1009. [PMID: 28246473 DOI: 10.3748/wjg.v23.i6.999] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
10 Lanis JM, Kao DJ, Alexeev EE, Colgan SP. Tissue metabolism and the inflammatory bowel diseases. J Mol Med (Berl). 2017;95:905-913. [PMID: 28528514 DOI: 10.1007/s00109-017-1544-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
11 Asano T, Takenaga M. Adenosine A2B Receptors: An Optional Target for the Management of Irritable Bowel Syndrome with Diarrhea? J Clin Med 2017;6:E104. [PMID: 29099770 DOI: 10.3390/jcm6110104] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
12 Pallio G, Bitto A, Pizzino G, Galfo F, Irrera N, Squadrito F, Squadrito G, Pallio S, Anastasi GP, Cutroneo G, Macrì A, Altavilla D. Adenosine Receptor Stimulation by Polydeoxyribonucleotide Improves Tissue Repair and Symptomology in Experimental Colitis. Front Pharmacol 2016;7:273. [PMID: 27601997 DOI: 10.3389/fphar.2016.00273] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
13 Allard B, Allard D, Buisseret L, Stagg J. The adenosine pathway in immuno-oncology. Nat Rev Clin Oncol 2020;17:611-29. [PMID: 32514148 DOI: 10.1038/s41571-020-0382-2] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 43.0] [Reference Citation Analysis]
14 Chang D, Whiteley AT, Bugda Gwilt K, Lencer WI, Mekalanos JJ, Thiagarajah JR. Extracellular cyclic dinucleotides induce polarized responses in barrier epithelial cells by adenosine signaling. Proc Natl Acad Sci U S A 2020;117:27502-8. [PMID: 33087577 DOI: 10.1073/pnas.2015919117] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
15 Ngamsri KC, Fabian F, Fuhr A, Gamper-Tsigaras J, Straub A, Fecher D, Steinke M, Walles H, Reutershan J, Konrad FM. Sevoflurane Exerts Protective Effects in Murine Peritonitis-induced Sepsis via Hypoxia-inducible Factor 1α/Adenosine A2B Receptor Signaling. Anesthesiology 2021;135:136-50. [PMID: 33914856 DOI: 10.1097/ALN.0000000000003788] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Bahreyni A, Samani SS, Khazaei M, Ryzhikov M, Avan A, Hassanian SM. Therapeutic potentials of adenosine receptors agonists and antagonists in colitis; Current status and perspectives. J Cell Physiol 2018;233:2733-40. [DOI: 10.1002/jcp.26073] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
17 Yuan X, Lee JW, Bowser JL, Neudecker V, Sridhar S, Eltzschig HK. Targeting Hypoxia Signaling for Perioperative Organ Injury. Anesth Analg 2018;126:308-21. [PMID: 28759485 DOI: 10.1213/ANE.0000000000002288] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 9.7] [Reference Citation Analysis]
18 Neudecker V, Colgan SP, Eltzschig HK. Novel therapeutic concepts for inflammatory bowel disease-from bench to bedside. J Mol Med (Berl) 2017;95:899-903. [PMID: 28780611 DOI: 10.1007/s00109-017-1574-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
19 Ulker P, Ozkan O, Amoroso M, Aslan M, Bassorgun I, Ubur MC, Ünal K, Ozcan F, Ozkan O. Does ischemic preconditioning increase flap survival by ADORA2B receptor activation? Clin Hemorheol Microcirc 2020;75:151-62. [PMID: 31985456 DOI: 10.3233/CH-190730] [Reference Citation Analysis]
20 Ngamsri KC, Jans C, Putri RA, Schindler K, Gamper-Tsigaras J, Eggstein C, Köhler D, Konrad FM. Inhibition of CXCR4 and CXCR7 Is Protective in Acute Peritoneal Inflammation. Front Immunol 2020;11:407. [PMID: 32210974 DOI: 10.3389/fimmu.2020.00407] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
21 Singhal R, Shah YM. Oxygen battle in the gut: Hypoxia and hypoxia-inducible factors in metabolic and inflammatory responses in the intestine. J Biol Chem 2020;295:10493-505. [PMID: 32503843 DOI: 10.1074/jbc.REV120.011188] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 20.0] [Reference Citation Analysis]
22 Harvey JB, Phan LH, Villarreal OE, Bowser JL. CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers. Front Immunol 2020;11:508. [PMID: 32351498 DOI: 10.3389/fimmu.2020.00508] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 17.0] [Reference Citation Analysis]
23 Hall CHT, Campbell EL, Colgan SP. Neutrophils as Components of Mucosal Homeostasis. Cell Mol Gastroenterol Hepatol 2017;4:329-37. [PMID: 28884136 DOI: 10.1016/j.jcmgh.2017.07.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
24 Cartwright IM, Curtis VF, Lanis JM, Alexeev EE, Welch N, Goldberg MS, Schaefer REM, Gao RY, Chun C, Fennimore B, Onyiah JC, Gerich ME, Dempsey PJ, Colgan SP. Adaptation to inflammatory acidity through neutrophil-derived adenosine regulation of SLC26A3. Mucosal Immunol 2020;13:230-44. [PMID: 31792360 DOI: 10.1038/s41385-019-0237-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
25 Burnstock G, Jacobson KA, Christofi FL. Purinergic drug targets for gastrointestinal disorders. Curr Opin Pharmacol 2017;37:131-41. [PMID: 29149731 DOI: 10.1016/j.coph.2017.10.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
26 Huang L, Fan J, Chen YX, Wang JH. Inhibition of A2B Adenosine Receptor Attenuates Intestinal Injury in a Rat Model of Necrotizing Enterocolitis. Mediators Inflamm 2020;2020:1562973. [PMID: 32714089 DOI: 10.1155/2020/1562973] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Chandrasekaran B, Samarneh S, Jaber AMY, Kassab G, Agrawal N. Therapeutic Potentials of A2B Adenosine Receptor Ligands: Current Status and Perspectives. Curr Pharm Des 2019;25:2741-71. [PMID: 31333084 DOI: 10.2174/1381612825666190717105834] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 13.0] [Reference Citation Analysis]
28 Van Welden S, Selfridge AC, Hindryckx P. Intestinal hypoxia and hypoxia-induced signalling as therapeutic targets for IBD. Nat Rev Gastroenterol Hepatol 2017;14:596-611. [PMID: 28853446 DOI: 10.1038/nrgastro.2017.101] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 10.0] [Reference Citation Analysis]
29 Jafari SM, Joshaghani HR, Panjehpour M, Aghaei M. A2B adenosine receptor agonist induces cell cycle arrest and apoptosis in breast cancer stem cells via ERK1/2 phosphorylation. Cell Oncol (Dordr) 2018;41:61-72. [PMID: 29218545 DOI: 10.1007/s13402-017-0359-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
30 Phillipson M, Kubes P. The Healing Power of Neutrophils. Trends Immunol 2019;40:635-47. [PMID: 31160208 DOI: 10.1016/j.it.2019.05.001] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 23.5] [Reference Citation Analysis]
31 Olli KE, Rapp C, O'Connell L, Collins CB, McNamee EN, Jensen O, Jedlicka P, Allison KC, Goldberg MS, Gerich ME, Frank DN, Ir D, Robertson CE, Evans CM, Aherne CM. Muc5ac Expression Protects the Colonic Barrier in Experimental Colitis. Inflamm Bowel Dis 2020;26:1353-67. [PMID: 32385500 DOI: 10.1093/ibd/izaa064] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
32 Bowser JL, Phan LH, Eltzschig HK. The Hypoxia-Adenosine Link during Intestinal Inflammation. J Immunol 2018;200:897-907. [PMID: 29358413 DOI: 10.4049/jimmunol.1701414] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 8.3] [Reference Citation Analysis]
33 Borea PA, Gessi S, Merighi S, Vincenzi F, Varani K. Pharmacology of Adenosine Receptors: The State of the Art. Physiol Rev 2018;98:1591-625. [PMID: 29848236 DOI: 10.1152/physrev.00049.2017] [Cited by in Crossref: 206] [Cited by in F6Publishing: 156] [Article Influence: 68.7] [Reference Citation Analysis]
34 Crittenden S, Cheyne A, Adams A, Forster T, Robb CT, Felton J, Ho GT, Ruckerl D, Rossi AG, Anderton SM, Ghazal P, Satsangi J, Howie SE, Yao C. Purine metabolism controls innate lymphoid cell function and protects against intestinal injury. Immunol Cell Biol 2018;96:1049-59. [PMID: 29758102 DOI: 10.1111/imcb.12167] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
35 Hardesty JE, Warner JB, Song YL, Rouchka EC, Chen CY, Kang JX, McClain CJ, Warner DR, Kirpich IA. Transcriptional signatures of the small intestinal mucosa in response to ethanol in transgenic mice rich in endogenous n3 fatty acids. Sci Rep 2020;10:19930. [PMID: 33199802 DOI: 10.1038/s41598-020-76959-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
36 D'Antongiovanni V, Fornai M, Pellegrini C, Benvenuti L, Blandizzi C, Antonioli L. The Adenosine System at the Crossroads of Intestinal Inflammation and Neoplasia. Int J Mol Sci 2020;21:E5089. [PMID: 32708507 DOI: 10.3390/ijms21145089] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
37 Aherne CM, Collins CB, Rapp CR, Olli KE, Perrenoud L, Jedlicka P, Bowser JL, Mills TW, Karmouty-Quintana H, Blackburn MR, Eltzschig HK. Coordination of ENT2-dependent adenosine transport and signaling dampens mucosal inflammation. JCI Insight 2018;3:121521. [PMID: 30333323 DOI: 10.1172/jci.insight.121521] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
38 Zhao L, Zhao J, Gao R, Tian Y, Zhang Y, Tang W, Jiang Y, Li C, Wang M, Yang F, Li G. Intrabody against prolyl hydroxylase 2 ameliorates acetaminophen-induced acute liver injury in mice via concomitant promotion of angiogenesis and redox homeostasis. Biomedicine & Pharmacotherapy 2020;123:109783. [DOI: 10.1016/j.biopha.2019.109783] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
39 Antonioli L, Blandizzi C, Pacher P, Haskó G. The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases. Pharmacol Rev 2019;71:345-82. [PMID: 31235653 DOI: 10.1124/pr.117.014878] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 26.5] [Reference Citation Analysis]
40 Li J, Conrad C, Mills TW, Berg NK, Kim B, Ruan W, Lee JW, Zhang X, Yuan X, Eltzschig HK. PMN-derived netrin-1 attenuates cardiac ischemia-reperfusion injury via myeloid ADORA2B signaling. J Exp Med 2021;218:e20210008. [PMID: 33891683 DOI: 10.1084/jem.20210008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Antonioli L, Fornai M, Pellegrini C, Bertani L, Nemeth ZH, Blandizzi C. Inflammatory Bowel Diseases: It's Time for the Adenosine System. Front Immunol 2020;11:1310. [PMID: 32849492 DOI: 10.3389/fimmu.2020.01310] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
42 Lee TJ, Yuan X, Kerr K, Yoo JY, Kim DH, Kaur B, Eltzschig HK. Strategies to Modulate MicroRNA Functions for the Treatment of Cancer or Organ Injury. Pharmacol Rev 2020;72:639-67. [PMID: 32554488 DOI: 10.1124/pr.119.019026] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
43 Ercan G, Yigitturk G, Erbas O. Therapeutic effect of adenosine on experimentally induced acute ulcerative colitis model in rats. Acta Cir Bras 2020;34:e201901204. [PMID: 32074166 DOI: 10.1590/s0102-865020190120000004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Fukuda T, Majumder K, Zhang H, Turner PV, Matsui T, Mine Y. Adenine Inhibits TNF-α Signaling in Intestinal Epithelial Cells and Reduces Mucosal Inflammation in a Dextran Sodium Sulfate-Induced Colitis Mouse Model. J Agric Food Chem 2016;64:4227-34. [DOI: 10.1021/acs.jafc.6b00665] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
45 Borea PA, Gessi S, Merighi S, Vincenzi F, Varani K. Pathological overproduction: the bad side of adenosine. Br J Pharmacol 2017;174:1945-60. [PMID: 28252203 DOI: 10.1111/bph.13763] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 14.0] [Reference Citation Analysis]
46 Li X, Berg NK, Mills T, Zhang K, Eltzschig HK, Yuan X. Adenosine at the Interphase of Hypoxia and Inflammation in Lung Injury. Front Immunol 2020;11:604944. [PMID: 33519814 DOI: 10.3389/fimmu.2020.604944] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
47 Fukuda T, Majumder K, Zhang H, Matsui T, Mine Y. Adenine has an anti-inflammatory effect through the activation of adenine receptor signaling in mouse macrophage. Journal of Functional Foods 2017;28:235-9. [DOI: 10.1016/j.jff.2016.11.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
48 Cummins EP, Crean D. Hypoxia and inflammatory bowel disease. Microbes and Infection 2017;19:210-21. [DOI: 10.1016/j.micinf.2016.09.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
49 Campbell EL, Colgan SP. Control and dysregulation of redox signalling in the gastrointestinal tract. Nat Rev Gastroenterol Hepatol 2019;16:106-20. [PMID: 30443019 DOI: 10.1038/s41575-018-0079-5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 16.5] [Reference Citation Analysis]
50 Borea PA, Gessi S, Merighi S, Varani K. Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? Trends Pharmacol Sci 2016;37:419-34. [PMID: 26944097 DOI: 10.1016/j.tips.2016.02.006] [Cited by in Crossref: 154] [Cited by in F6Publishing: 129] [Article Influence: 30.8] [Reference Citation Analysis]